TABLE 3

Univariate and Multivariate Analyses of Factors Predicting OS

FactorNo. of subjects/deathsCrude RRPAdjusted RRP
Sex
 Male129/571 (ref)<0.0011 (ref)<0.001
 Female221/550.42 (0.29–0.62)0.49 (0.33–0.74)
Age at the diagnosis of distant metastasis (y)
 0–2980/31 (ref)1 (ref)
 30–3954/116.43 (1.79–23.10)4.54 (1.24–16.61)
 40–4956/189.87 (2.91–33.52)<0.00017.65 (2.22–26.32)<0.0001
 50–5970/3121.57 (6.55–71.10)11.49 (3.33–39.59)
 60–6957/3123.60 (7.15–77.95)13.18 (3.83–45.31)
 70–9035/1842.88 (12.39–148.37)23.03 (6.24–85.08)
Extent of metastases
 Category 183/81 (ref)1 (ref)
 Category 2109/313.65 (1.68–7.94)<0.0012.71 (1.22–6.03)<0.01
 Category 3160/738.43 (4.04–17.58)3.49 (1.56–7.81)
Site of metastases
 Lung205/511 (ref)1 (ref)
 Bone84/322.17 (1.38–3.39)<0.0011.33 (0.77–2.31)0.24
 Lung and bone ± other63/293.58 (2.24–5.72)1.63 (0.92–2.91)
Histology
 Papillary thyroid carcinoma245/721 (ref)1 (ref)
 Follicular thyroid carcinoma107/401.61 (1.09–2.39)0.020.67 (0.42–1.07)0.09
Center
 GR231/681 (ref)1 (ref)
 MSKCC121/441.77 (1.20–2.62)0.011.41 (0.87–2.29)0.16
  • ref = reference; Category 1 = patients with metastases on 131I WB scan but with normal radiologic imaging; category 2 = patients with micronodular lung metastases defined radiologically < 1 cm or with a single bone metastasis identified radiologically; category 3 = macronodular lung metastases or multiple bone metastases or both bone and lung metastases.

  • Data in parentheses are 95% CIs.